Specialised Pharmaceutical Formulation: The Science and Technology of Dosage Forms
Formulation is a key step in the drug design process, where the active drug is combined with other substances that maximise the therapeutic potential, safety, and stability of the final medicinal product. Regulatory and quality demands, in addition to advances in processing technologies, result in growing challenges as well as possibilities for the field.
Following on from Pharmaceutical Formulation, which covered traditional dosage forms such as tablets and capsules, this volume expands upon those formulations to cover a more diverse range of less common dosage forms. Novel routes of administration are covered from inhalational, dermal and transdermal formulations to ocular, oral suspensions, vaccines and nanoparticle drug delivery. The methods through which these formulations are processed and manufactured is also covered, providing essential knowledge to ensure quality, efficiency, and acceptable costing.
Specialised Pharmaceutical Formulation is an essential, up to date resource for students and researchers working in academia and in the pharmaceutical industry and will equip readers with the ability to effectively and reliably produce products which can be approved, manufactured and made available to administer to patients.
Specialised Pharmaceutical Formulation: The Science and Technology of Dosage Forms, The Royal Society of Chemistry, 2022.
Download citation file:
Digital access
Print format
Table of contents
-
Chapter 1: Ophthalmic Formulationp1-44ByClive G. WilsonClive G. WilsonSearch for other works by this author on:
-
Chapter 2: Parenteral Productsp45-74ByR. HolmR. HolmDepartment of Physics, Chemistry and Pharmacy, University of Southern DenmarkCampusvej 555230 Odense MDenmark[email protected]Search for other works by this author on:
-
Chapter 3: Dermal Formulations for Local Treatmentp75-93ByMajella E. Lane;Majella E. LaneUniversity College London, School of Pharmacy29–39 Brunswick SquareLondonWC1N 1AXUnited Kingdom[email protected]Search for other works by this author on:Nicola ParisiNicola ParisiSeda Pharmaceutical Development Services, The BioHub at Alderley ParkAlderley EdgeSK10 4TGUnited KingdomSearch for other works by this author on:
-
Chapter 4: Transdermal Drug Deliveryp94-120ByQonita Kurnia Anjani;Qonita Kurnia AnjaniSchool of Pharmacy, Queen's University Belfast97 Lisburn RoadBelfast, BT9 7BLUnited Kingdom[email protected]Search for other works by this author on:Akmal Hidayat Bin Sabri;Akmal Hidayat Bin SabriSchool of Pharmacy, Queen's University Belfast97 Lisburn RoadBelfast, BT9 7BLUnited Kingdom[email protected]Search for other works by this author on:Stefan Henke;Stefan HenkeLTS Lohmann Therapie-Systeme AGLohmannstraße 256626 AndernachGermanySearch for other works by this author on:Ryan F. DonnellyRyan F. DonnellySchool of Pharmacy, Queen's University Belfast97 Lisburn RoadBelfast, BT9 7BLUnited Kingdom[email protected]Search for other works by this author on:
-
Chapter 5: Oral Suspensionsp121-150ByM. CavinatoM. CavinatoGSK Consumer Healthcare, Research and DevelopmentRoute de l'Etraz 2CH-1260 NyonSwitzerland[email protected]Search for other works by this author on:
-
Chapter 6: Oral Filmsp151-174ByMarshall WhitemanMarshall WhitemanSearch for other works by this author on:
-
Chapter 7: Inhalation Devices and Formulationsp175-210ByA. P. SavageA. P. SavageSearch for other works by this author on:
-
Chapter 8: Advanced Therapy Medicinal Products (ATMPs)p211-229ByM. L. D. Rayner;M. L. D. RaynerUCL School of Pharmacy, University College London29-39 Brunswick SquareLondonW1CN 1AXUK[email protected]Search for other works by this author on:J. B. PhillipsJ. B. PhillipsUCL School of Pharmacy, University College London29-39 Brunswick SquareLondonW1CN 1AXUK[email protected]Search for other works by this author on:
-
Chapter 9: Geriatric Pharmaceuticsp230-258ByNeel Desai;Neel DesaiDepartment of Pharmaceutics, UCL School of Pharmacy, University College London, Brunswick SquareLondonWC1N 1AXUnited Kingdom[email protected]Search for other works by this author on:Laura E. McCoubrey;Laura E. McCoubreyDepartment of Pharmaceutics, UCL School of Pharmacy, University College London, Brunswick SquareLondonWC1N 1AXUnited Kingdom[email protected]Search for other works by this author on:Christine M. Madla;Christine M. MadlaDepartment of Pharmaceutics, UCL School of Pharmacy, University College London, Brunswick SquareLondonWC1N 1AXUnited Kingdom[email protected]Search for other works by this author on:Francesca K. H. Gavins;Francesca K. H. GavinsDepartment of Pharmaceutics, UCL School of Pharmacy, University College London, Brunswick SquareLondonWC1N 1AXUnited Kingdom[email protected]Search for other works by this author on:Mine OrluMine OrluDepartment of Pharmaceutics, UCL School of Pharmacy, University College London, Brunswick SquareLondonWC1N 1AXUnited Kingdom[email protected]Search for other works by this author on:
-
Chapter 10: Development Programs for Oral Fixed Dose Combination Productsp259-286ByLuigi G. Martini;Luigi G. MartiniRoyal Pharmaceutical Society; 66–68 East SmithfieldLondonE1W 1AWUnited KingdomSearch for other works by this author on:David TempletonDavid TempletonPharmaceutical ConsultantWelwyn Garden CityHertfordshireUKSearch for other works by this author on:
-
Chapter 11: Presentational and Organoleptic Aspects of Formulationp287-320ByD. ClaphamD. ClaphamSearch for other works by this author on:
-
Chapter 12: Formulation and Processing for Powder Sachetsp321-338ByKendal PittKendal PittSearch for other works by this author on:
Spotlight
Advertisement
Advertisement